Put Option Activity Highlights
Among the most actively traded put options for Sun Pharmaceutical Industries, contracts with strike prices of ₹1,760 and ₹1,740 have dominated volumes. Specifically, the ₹1,740 strike put options recorded 3,385 contracts traded, generating a turnover of approximately ₹17.25 crores, alongside an open interest of 943 contracts. Meanwhile, the ₹1,760 strike put options saw 2,113 contracts traded with a turnover near ₹15.94 crores and an open interest of 763 contracts. These figures indicate a substantial level of bearish positioning or hedging interest in the stock as expiry nears.
Price and Market Context
Sun Pharmaceutical Industries’ underlying stock price stood at ₹1,755.20 during this period, with the stock touching an intraday low of ₹1,746.10, reflecting a decline of 2.61% on the day. The stock underperformed its sector by 1.38% and the broader Sensex by 2.22% on the same day, signalling some pressure on the share price amid broader market conditions.
Despite this, the stock price remains above its 50-day, 100-day, and 200-day moving averages, though it is trading below the 5-day and 20-day averages. This mixed technical picture suggests short-term weakness amid longer-term support levels.
Investor Participation and Liquidity
Investor engagement has shown signs of rising interest, with delivery volumes reaching 15.2 lakh shares on 17 December 2025, marking a 28.62% increase compared to the five-day average delivery volume. This heightened participation indicates active trading and potential repositioning by market participants ahead of the options expiry.
Liquidity metrics also support the stock’s tradability, with the average traded value over five days sufficient to accommodate trade sizes of approximately ₹5.7 crores, ensuring that investors can execute sizeable transactions without significant market impact.
Just announced: This Small Cap from Tyres & Allied with precise target price is our pick for the week. Get the pre-market insights that informed this selection!
- - Just announced pick
- - Pre-market insights shared
- - Tyres & Allied weekly focus
Interpreting the Put Option Interest
The concentration of put option contracts at strike prices slightly below the current market price suggests that investors are positioning for potential downside or seeking protection against further declines. The open interest figures, particularly at the ₹1,740 strike, indicate that a sizeable number of contracts remain outstanding, which could influence price dynamics as expiry approaches.
Put options serve as a tool for hedging existing long positions or speculating on downward price movements. The elevated turnover and open interest in these strikes imply that market participants are actively managing risk or expressing caution regarding Sun Pharmaceutical Industries’ near-term prospects.
Sector and Market Comparison
Within the Pharmaceuticals & Biotechnology sector, Sun Pharmaceutical Industries is a large-cap entity with a market capitalisation of approximately ₹4,21,467 crores. The sector itself experienced a 0.96% decline on the day, while the Sensex recorded a more modest fall of 0.25%. Sun Pharma’s sharper decline relative to the sector and benchmark indices may be contributing to the increased put option activity as investors seek downside protection.
Such sector-relative performance is an important consideration for investors analysing risk exposure and hedging needs within their portfolios.
Expiry Patterns and Market Sentiment
The 30 December 2025 expiry date for these options is less than two weeks away, a period during which option traders often adjust positions to manage risk or capitalise on anticipated price movements. The clustering of put option activity near the current stock price suggests a market expectation of potential volatility or a cautious outlook for Sun Pharmaceutical Industries in the short term.
Expiry-related dynamics can lead to increased price swings as traders close or roll over positions, making this period critical for monitoring stock behaviour and option market signals.
Want to dive deeper on Sun Pharmaceutical Industries ? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Outlook for Investors
For investors and traders, the current put option activity in Sun Pharmaceutical Industries highlights the importance of closely monitoring price levels around ₹1,740 to ₹1,760. These strikes represent key thresholds where market participants have concentrated their hedging or bearish bets.
Given the stock’s recent underperformance relative to its sector and the broader market, alongside the technical signals from moving averages, cautious positioning may be warranted. However, the stock’s standing above longer-term moving averages suggests underlying support that could limit downside risk.
Investors should also consider the broader pharmaceutical sector trends, regulatory developments, and company-specific news that could influence price movements in the coming weeks.
Summary
Sun Pharmaceutical Industries is currently experiencing significant put option trading activity, particularly at strike prices near ₹1,740 and ₹1,760, ahead of the 30 December 2025 expiry. This activity reflects a degree of bearish sentiment or risk management among market participants amid recent price declines and sector pressures.
With the stock’s price hovering just above these strike levels and showing mixed technical signals, the coming days will be crucial in determining whether the put option interest translates into further price weakness or stabilisation. Investors should remain attentive to option market developments as part of their broader analysis of Sun Pharmaceutical Industries’ outlook.
Only Rs. 14,999 - Get MojoOne + Stock of the Week for 1 Year PLUS 18 Months FREE! Start Saving Now →
